American College of Clinical Pharmacy
      Search      Cart
         

CardSAP 2024 Book 2 Arrhythmias and Thrombosis


Member Price:
$80.00
Nonmember Price:
$120.00
ASHP members, please call (913)492-3311 to recieve member pricing. Your ASHP membership number and expiration date are required.

The management of arrhythmias can be complex and often involves the use of multiple high-risk agents including antiarrhythmics and anticoagulation. As such, it is critical for clinicians to be up to date on issues regarding the assessment and management of atrial and ventricular arrhythmias. The need for anticoagulation creates an opportunity for the advancement of clinical pharmacy practice as well. Arrhythmias and Thrombosis, the latest release in ACCP's Cardiology Self-Assessment Program (CardSAP), provides evidence-based updates for pharmacists managing arrhythmia related disorders and opportunities for pharmacist involvement in areas of cardiovascular care.

Faculty Panel Chair Kristen Bova Campbell, Pharm.D., BCPS (AQ-Cardiology), CPP, FACC
Campbell

The target audience for Arrhythmias and Thrombosis is board-certified cardiology pharmacy specialists caring for patients with cardiovascular diseases being treated across all care areas. Arrhythmias and Thrombosis has five modules offering a total of 21.5 available continuing pharmacy education (CPE) credits. The book was developed under the leadership of Faculty Panel Chair Kristen Bova Campbell, Pharm.D., BCPS (AQ-Cardiology), CPP, FACC.

Chapters in the first module provide an overview of ECG interpretation as well as the positive effect of pharmacist involvement in atrial fibrillation clinics. The second module focuses on ventricular tachycardia and the role of antiarrhythmics versus ablation in the management of atrial fibrillation. The third module examines the growing evidence for wearable devices for detection of atrial fibrillation as well as risk factor modification and lifestyle modifications for atrial fibrillation. The fourth module details antithrombotic therapy for patients with valvular heart disease. And the final module comprises two features: a case series on left ventricular thrombus; and a recorded webcast focusing on the management of supraventricular tachycardia.

Each CardSAP release has continuing education activities that cover the most recent published data (past 3–5 years) on a specific therapeutic area or patient-care problem. This content is provided as a full-color electronic book (interactive PDF) with high-level updates designed, as appropriate to the topic, in three formats:

  • Traditional review-style chapters
  • Case series (major sections of learning content bookended by a sample case and its explained answer)
  • Recorded webcast (PowerPoint presentation; includes PDF of the transcribed narrative)

CardSAP chapters and features are fully referenced, with clickable hyperlinks to literature compilers such as PubMed. Other links provide ready access to clinical practice guidelines, official recommendations, and patient assessment tools. Graphics focus on pivotal studies, patient care scenarios, and take-home points that can be readily integrated into clinical practice. Included with every purchase is an e-media version you can view on an e-reader, tablet, and iOS or Android smart phone. 

Release Date: November 15, 2024
BCCP Deadline: November 14, 2025
ACPE Deadline: November 15, 2027

ISBN: 978-1-964074-11-5
Publication Year: 2024
Format: PDF and ePub
Number of Pages: 200

CPE Credit

The American College of Clinical Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

The American Society of Health-System Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education with Commendation.

The American College of Clinical Pharmacy and the American Society of Health-System Pharmacists are approved by BPS as a provider for the recertification of of BCCP.

BPS is an autonomous division of the American Pharmacists Association. To maintain its strict, independent standards for certification, BPS does NOT endorse or provide review information, preparatory courses, or study guides for board certification examinations. BPS, through its specialty councils, is responsible for specialty examination content, administration, scoring, and all other aspects of its certification programs. BPS is totally separate and distinct from ACCP. For information about BPS specialty recertification the BPS recertification process, go to: www.bpsweb.org/

To receive recertification credit, posttests must be submitted prior to the recertification posttest deadline (see above). Only completed tests are eligible for credit; no partial or incomplete tests will be processed. You may complete one or all available posttests for credit.

The passing point to earn recertification credit is based on an expert analysis of the assessment items in each posttest. Any posttest submitted before the recertification test deadline that meets this passing point will earn recertification credits. These credits will be assigned as of the date of test submission and reported within 48 hours to BPS. For statements of recertification credit, visit www.bpsweb.org.

In accordance with BPS guidelines concerning remediation for products launched in 2024 and after, posttests that do not reach the passing point for recertification credit will generate a second-chance test option. This test will automatically appear in the learner’s My Account page and will have assessment items presented in a different order. To qualify for recertification credit, the second-chance test must be submitted before the recertification deadline stated above.

The ACCP Recertification Dashboard is a free online tool that can track recertification credits as they are earned through ACCP and schedule new opportunities for credits from upcoming ACCP professional development programs. Questions regarding the number of hours required for recertification should be directed to BPS at www.bpsweb.org.


Commercial Support

The American College of Clinical Pharmacy does not solicit or accept external commercial/financial support for its continuing pharmacy education activities. No commercial/financial support has been solicited or accepted for this activity.